![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283812008342-gr2.jpg)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect
![Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fpcan.2016.57/MediaObjects/41391_2017_Article_BFpcan201657_Fig1_HTML.jpg)
Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases
Indonesian Prostate Cancer Risk Calculator (IPCRC): An application for Predicting Prostate Cancer Risk (a Multicenter Study)
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/5-Figure2-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov-2-FI.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice](https://bjgp.org/content/bjgp/71/706/e364/F1.large.jpg)
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
Society of Urologic Oncology - A PROSTATE BIOPSY RISK CALCULATOR BASED ON MAGNETIC RESONANCE IMAGING: DEVELOPMENT AND COMPARISON TO THE PBCG RISK CALCULATOR
![IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies](https://www.mdpi.com/ijms/ijms-24-02449/article_deploy/html/images/ijms-24-02449-g001.png)